http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114903988-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7641d8ec4b289baa8268f4936e0e4635
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
filingDate 2022-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddb980530651aac7c0fdeee07a428cb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9127cf3287164b56df8557f98b1c21aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5795ea1f666187c4ccc1cb976d1c0f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8031d7b9d31a45448db200831318024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d1a1380b4587bdee543bf6db3f34335
publicationDate 2022-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114903988-A
titleOfInvention A kind of sepiolite in situ growth nanozyme and its preparation method and application
abstract The invention relates to the technical field of nanomaterials for vaccines, in particular to a sepiolite in-situ growth nanozyme and a preparation method and application thereof. The preparation method comprises mixing ferric chloride, ethylene glycol and sodium acetate to form a suspension, Then, the sepiolite is mixed with the suspension, reacted at a temperature of 180-200° C. to obtain a black precipitate, and then washed and dried to obtain the sepiolite in-situ growth nanozyme. Sepiolite nanozymes achieved in situ growth of iron-based nanozymes on the surface of sepiolite rod-like nanostructures under hydrothermal conditions, which significantly enhanced the peroxidase activity. After Sep@IONzyme is connected to the inactivated influenza virus, the complex forms an appropriate distribution of positive charges, which enhances the adhesion of the antigen to the nasal mucosa. Using it as a nasal vaccine to immunize mice significantly improves the respiratory mucosa-specific sIgA Antibody levels and serum-specific IgG antibody levels provide complete protection against lethal challenge with influenza virus.
priorityDate 2022-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452873552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185

Total number of triples: 30.